cbdMD Secures $2.8M Via Underwritten Public Offering Of Common Stock

cbdMD, Inc. YCBD announced the closing of its underwritten public offering of 1.35 million shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering before deducting underwriting discounts and commissions and offering expenses were approximately $2.8 million.

Maxim Group LLC acted as sole book-running manager for the offering.

The public offering was made pursuant to an effective shelf registration statement on Form S-3, previously filed with the U.S. Securities and Exchange Commission on April 5, 2022 and declared effective on April 21, 2022. The shares of common stock were offered only by means of a prospectus and prospectus supplement that form part of the effective registration statement. A final prospectus supplement describing the terms of the public offering has been filed with the SEC and is available on the SEC's website located at www.sec.gov.

Price Action

cbdMD shares were trading 5.18% higher at $2.03 during Thursday’s pre-market session.

Photo: Benzinga edit with photo by Kindel Media on Pexels

Related News

cbdMD Expands Its Reach To The United Kingdom With Launch On Amazon UK

Wellness Company Milestone: First CBD Brand To Attain Three NSF Certifications For Sports

cbdMD Q1 Net Sales Decline 35% YoY, What About Net Loss?

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketsMaxim Grouppremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.